[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Biosimilars Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery

October 2021 | 111 pages | ID: G4B18D0AC31BEN
Maia Research

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that is manufactured by a different company.Biosimilars are officially approved versions of original 'innovator' products and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.

Based on the Biosimilars market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.

In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.

In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global Biosimilars market covered in Chapter 5:

Samsung Bioepis
Dr. Reddy’s Laboratories Ltd.
Biocon
F. Hoffmann-La Roche Ltd.
Mylan N.V
Pfizer Inc.
Amgen Inc
Sandoz International GmbH
Teva Pharmaceutical Industries Ltd.

In Chapter 6, on the basis of types, the Biosimilars market from 2015 to 2025 is primarily split into:

Recombinant Non-Glycosylated Proteins
Recombinant Glycosylated Proteins

In Chapter 7, on the basis of applications, the Biosimilars market from 2015 to 2025 covers:

Oncology
Blood Disorders
Growth Hormonal Deficiency
Chronic and Autoimmune Disorders
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:

North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa

Years considered for this report:

Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 MARKET OVERVIEW

1.1 Product Definition and Market Characteristics
1.2 Global Biosimilars Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis

2. MARKET DYNAMICS

2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
  2.4.1 Short-term Impact
  2.4.2 Long-term Impact

3 ASSOCIATED INDUSTRY ASSESSMENT

3.1 Supply Chain Analysis
3.2 Industry Active Participants
  3.2.1 Suppliers of Raw Materials
  3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 MARKET COMPETITIVE LANDSCAPE

4.1 Industry Leading Players
4.2 Industry News
  4.2.1 Key Product Launch News
  4.2.2 M&A and Expansion Plans

5 ANALYSIS OF LEADING COMPANIES

5.1 Samsung Bioepis
  5.1.1 Samsung Bioepis Company Profile
  5.1.2 Samsung Bioepis Business Overview
  5.1.3 Samsung Bioepis Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.1.4 Samsung Bioepis Biosimilars Products Introduction
5.2 Dr. Reddy’s Laboratories Ltd.
  5.2.1 Dr. Reddy’s Laboratories Ltd. Company Profile
  5.2.2 Dr. Reddy’s Laboratories Ltd. Business Overview
  5.2.3 Dr. Reddy’s Laboratories Ltd. Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.2.4 Dr. Reddy’s Laboratories Ltd. Biosimilars Products Introduction
5.3 Biocon
  5.3.1 Biocon Company Profile
  5.3.2 Biocon Business Overview
  5.3.3 Biocon Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.3.4 Biocon Biosimilars Products Introduction
5.4 F. Hoffmann-La Roche Ltd.
  5.4.1 F. Hoffmann-La Roche Ltd. Company Profile
  5.4.2 F. Hoffmann-La Roche Ltd. Business Overview
  5.4.3 F. Hoffmann-La Roche Ltd. Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.4.4 F. Hoffmann-La Roche Ltd. Biosimilars Products Introduction
5.5 Mylan N.V
  5.5.1 Mylan N.V Company Profile
  5.5.2 Mylan N.V Business Overview
  5.5.3 Mylan N.V Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.5.4 Mylan N.V Biosimilars Products Introduction
5.6 Pfizer Inc.
  5.6.1 Pfizer Inc. Company Profile
  5.6.2 Pfizer Inc. Business Overview
  5.6.3 Pfizer Inc. Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.6.4 Pfizer Inc. Biosimilars Products Introduction
5.7 Amgen Inc
  5.7.1 Amgen Inc Company Profile
  5.7.2 Amgen Inc Business Overview
  5.7.3 Amgen Inc Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.7.4 Amgen Inc Biosimilars Products Introduction
5.8 Sandoz International GmbH
  5.8.1 Sandoz International GmbH Company Profile
  5.8.2 Sandoz International GmbH Business Overview
  5.8.3 Sandoz International GmbH Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.8.4 Sandoz International GmbH Biosimilars Products Introduction
5.9 Teva Pharmaceutical Industries Ltd.
  5.9.1 Teva Pharmaceutical Industries Ltd. Company Profile
  5.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
  5.9.3 Teva Pharmaceutical Industries Ltd. Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.9.4 Teva Pharmaceutical Industries Ltd. Biosimilars Products Introduction

6 MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPES

6.1 Global Biosimilars Sales, Revenue and Market Share by Types (2015-2020)
  6.1.1 Global Biosimilars Sales and Market Share by Types (2015-2020)
  6.1.2 Global Biosimilars Revenue and Market Share by Types (2015-2020)
  6.1.3 Global Biosimilars Price by Types (2015-2020)
6.2 Global Biosimilars Market Forecast by Types (2020-2025)
  6.2.1 Global Biosimilars Market Forecast Sales and Market Share by Types (2020-2025)
  6.2.2 Global Biosimilars Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Biosimilars Sales, Price and Growth Rate by Types (2015-2020)
  6.3.1 Global Biosimilars Sales, Price and Growth Rate of Recombinant Non-Glycosylated Proteins
  6.3.2 Global Biosimilars Sales, Price and Growth Rate of Recombinant Glycosylated Proteins
6.4 Global Biosimilars Market Revenue and Sales Forecast, by Types (2020-2025)
  6.4.1 Recombinant Non-Glycosylated Proteins Market Revenue and Sales Forecast (2020-2025)
  6.4.2 Recombinant Glycosylated Proteins Market Revenue and Sales Forecast (2020-2025)

7 MARKET ANALYSIS AND FORECAST, BY APPLICATIONS

7.1 Global Biosimilars Sales, Revenue and Market Share by Applications (2015-2020)
  7.1.1 Global Biosimilars Sales and Market Share by Applications (2015-2020)
  7.1.2 Global Biosimilars Revenue and Market Share by Applications (2015-2020)
7.2 Global Biosimilars Market Forecast by Applications (2020-2025)
  7.2.1 Global Biosimilars Market Forecast Sales and Market Share by Applications (2020-2025)
  7.2.2 Global Biosimilars Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
  7.3.1 Global Biosimilars Revenue, Sales and Growth Rate of Oncology (2015-2020)
  7.3.2 Global Biosimilars Revenue, Sales and Growth Rate of Blood Disorders (2015-2020)
  7.3.3 Global Biosimilars Revenue, Sales and Growth Rate of Growth Hormonal Deficiency (2015-2020)
  7.3.4 Global Biosimilars Revenue, Sales and Growth Rate of Chronic and Autoimmune Disorders (2015-2020)
  7.3.5 Global Biosimilars Revenue, Sales and Growth Rate of Others (2015-2020)
7.4 Global Biosimilars Market Revenue and Sales Forecast, by Applications (2020-2025)
  7.4.1 Oncology Market Revenue and Sales Forecast (2020-2025)
  7.4.2 Blood Disorders Market Revenue and Sales Forecast (2020-2025)
  7.4.3 Growth Hormonal Deficiency Market Revenue and Sales Forecast (2020-2025)
  7.4.4 Chronic and Autoimmune Disorders Market Revenue and Sales Forecast (2020-2025)
  7.4.5 Others Market Revenue and Sales Forecast (2020-2025)

8 MARKET ANALYSIS AND FORECAST, BY REGIONS

8.1 Global Biosimilars Sales by Regions (2015-2020)
8.2 Global Biosimilars Market Revenue by Regions (2015-2020)
8.3 Global Biosimilars Market Forecast by Regions (2020-2025)

9 NORTH AMERICA BIOSIMILARS MARKET ANALYSIS

9.1 Market Overview and Prospect Analysis
9.2 North America Biosimilars Market Sales and Growth Rate (2015-2020)
9.3 North America Biosimilars Market Revenue and Growth Rate (2015-2020)
9.4 North America Biosimilars Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Biosimilars Market Analysis by Country
  9.6.1 U.S. Biosimilars Sales and Growth Rate
  9.6.2 Canada Biosimilars Sales and Growth Rate
  9.6.3 Mexico Biosimilars Sales and Growth Rate

10 EUROPE BIOSIMILARS MARKET ANALYSIS

10.1 Market Overview and Prospect Analysis
10.2 Europe Biosimilars Market Sales and Growth Rate (2015-2020)
10.3 Europe Biosimilars Market Revenue and Growth Rate (2015-2020)
10.4 Europe Biosimilars Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Biosimilars Market Analysis by Country
  10.6.1 Germany Biosimilars Sales and Growth Rate
  10.6.2 United Kingdom Biosimilars Sales and Growth Rate
  10.6.3 France Biosimilars Sales and Growth Rate
  10.6.4 Italy Biosimilars Sales and Growth Rate
  10.6.5 Spain Biosimilars Sales and Growth Rate
  10.6.6 Russia Biosimilars Sales and Growth Rate

11 ASIA-PACIFIC BIOSIMILARS MARKET ANALYSIS

11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Biosimilars Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Biosimilars Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Biosimilars Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Biosimilars Market Analysis by Country
  11.6.1 China Biosimilars Sales and Growth Rate
  11.6.2 Japan Biosimilars Sales and Growth Rate
  11.6.3 South Korea Biosimilars Sales and Growth Rate
  11.6.4 Australia Biosimilars Sales and Growth Rate
  11.6.5 India Biosimilars Sales and Growth Rate

12 SOUTH AMERICA BIOSIMILARS MARKET ANALYSIS

12.1 Market Overview and Prospect Analysis
12.2 South America Biosimilars Market Sales and Growth Rate (2015-2020)
12.3 South America Biosimilars Market Revenue and Growth Rate (2015-2020)
12.4 South America Biosimilars Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Biosimilars Market Analysis by Country
  12.6.1 Brazil Biosimilars Sales and Growth Rate
  12.6.2 Argentina Biosimilars Sales and Growth Rate
  12.6.3 Columbia Biosimilars Sales and Growth Rate

13 MIDDLE EAST AND AFRICA BIOSIMILARS MARKET ANALYSIS

13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Biosimilars Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Biosimilars Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Biosimilars Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Biosimilars Market Analysis by Country
  13.6.1 UAE Biosimilars Sales and Growth Rate
  13.6.2 Egypt Biosimilars Sales and Growth Rate
  13.6.3 South Africa Biosimilars Sales and Growth Rate

14 CONCLUSIONS AND RECOMMENDATIONS

14.1 Key Market Findings and Prospects
14.2 Advice for Investors

15 APPENDIX

15.1 Methodology
15.2 Research Data Source
LIST OF TABLES AND FIGURES

Figure Product Picture
Figure Global Biosimilars Market Size and Growth Rate 2015-2025
Table Biosimilars Key Market Segments
Figure Global Biosimilars Market Revenue ($) Segment by Type from 2015-2020
Figure Global Biosimilars Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Biosimilars
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Samsung Bioepis Company Profile
Table Samsung Bioepis Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Samsung Bioepis Production and Growth Rate
Figure Samsung Bioepis Market Revenue ($) Market Share 2015-2020
Table Dr. Reddy’s Laboratories Ltd. Company Profile
Table Dr. Reddy’s Laboratories Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Dr. Reddy’s Laboratories Ltd. Production and Growth Rate
Figure Dr. Reddy’s Laboratories Ltd. Market Revenue ($) Market Share 2015-2020
Table Biocon Company Profile
Table Biocon Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Biocon Production and Growth Rate
Figure Biocon Market Revenue ($) Market Share 2015-2020
Table F. Hoffmann-La Roche Ltd. Company Profile
Table F. Hoffmann-La Roche Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure F. Hoffmann-La Roche Ltd. Production and Growth Rate
Figure F. Hoffmann-La Roche Ltd. Market Revenue ($) Market Share 2015-2020
Table Mylan N.V Company Profile
Table Mylan N.V Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Mylan N.V Production and Growth Rate
Figure Mylan N.V Market Revenue ($) Market Share 2015-2020
Table Pfizer Inc. Company Profile
Table Pfizer Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Pfizer Inc. Production and Growth Rate
Figure Pfizer Inc. Market Revenue ($) Market Share 2015-2020
Table Amgen Inc Company Profile
Table Amgen Inc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Amgen Inc Production and Growth Rate
Figure Amgen Inc Market Revenue ($) Market Share 2015-2020
Table Sandoz International GmbH Company Profile
Table Sandoz International GmbH Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Sandoz International GmbH Production and Growth Rate
Figure Sandoz International GmbH Market Revenue ($) Market Share 2015-2020
Table Teva Pharmaceutical Industries Ltd. Company Profile
Table Teva Pharmaceutical Industries Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Teva Pharmaceutical Industries Ltd. Production and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Market Revenue ($) Market Share 2015-2020
Table Global Biosimilars Sales by Types (2015-2020)
Table Global Biosimilars Sales Share by Types (2015-2020)
Table Global Biosimilars Revenue ($) by Types (2015-2020)
Table Global Biosimilars Revenue Share by Types (2015-2020)
Table Global Biosimilars Price ($) by Types (2015-2020)
Table Global Biosimilars Market Forecast Sales by Types (2020-2025)
Table Global Biosimilars Market Forecast Sales Share by Types (2020-2025)
Table Global Biosimilars Market Forecast Revenue ($) by Types (2020-2025)
Table Global Biosimilars Market Forecast Revenue Share by Types (2020-2025)
Figure Global Recombinant Non-Glycosylated Proteins Sales and Growth Rate (2015-2020)
Figure Global Recombinant Non-Glycosylated Proteins Price (2015-2020)
Figure Global Recombinant Glycosylated Proteins Sales and Growth Rate (2015-2020)
Figure Global Recombinant Glycosylated Proteins Price (2015-2020)
Figure Global Biosimilars Market Revenue ($) and Growth Rate Forecast of Recombinant Non-Glycosylated Proteins (2020-2025)
Figure Global Biosimilars Sales and Growth Rate Forecast of Recombinant Non-Glycosylated Proteins (2020-2025)
Figure Global Biosimilars Market Revenue ($) and Growth Rate Forecast of Recombinant Glycosylated Proteins (2020-2025)
Figure Global Biosimilars Sales and Growth Rate Forecast of Recombinant Glycosylated Proteins (2020-2025)
Table Global Biosimilars Sales by Applications (2015-2020)
Table Global Biosimilars Sales Share by Applications (2015-2020)
Table Global Biosimilars Revenue ($) by Applications (2015-2020)
Table Global Biosimilars Revenue Share by Applications (2015-2020)
Table Global Biosimilars Market Forecast Sales by Applications (2020-2025)
Table Global Biosimilars Market Forecast Sales Share by Applications (2020-2025)
Table Global Biosimilars Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Biosimilars Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Oncology Sales and Growth Rate (2015-2020)
Figure Global Oncology Price (2015-2020)
Figure Global Blood Disorders Sales and Growth Rate (2015-2020)
Figure Global Blood Disorders Price (2015-2020)
Figure Global Growth Hormonal Deficiency Sales and Growth Rate (2015-2020)
Figure Global Growth Hormonal Deficiency Price (2015-2020)
Figure Global Chronic and Autoimmune Disorders Sales and Growth Rate (2015-2020)
Figure Global Chronic and Autoimmune Disorders Price (2015-2020)
Figure Global Others Sales and Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Figure Global Biosimilars Market Revenue ($) and Growth Rate Forecast of Oncology (2020-2025)
Figure Global Biosimilars Sales and Growth Rate Forecast of Oncology (2020-2025)
Figure Global Biosimilars Market Revenue ($) and Growth Rate Forecast of Blood Disorders (2020-2025)
Figure Global Biosimilars Sales and Growth Rate Forecast of Blood Disorders (2020-2025)
Figure Global Biosimilars Market Revenue ($) and Growth Rate Forecast of Growth Hormonal Deficiency (2020-2025)
Figure Global Biosimilars Sales and Growth Rate Forecast of Growth Hormonal Deficiency (2020-2025)
Figure Global Biosimilars Market Revenue ($) and Growth Rate Forecast of Chronic and Autoimmune Disorders (2020-2025)
Figure Global Biosimilars Sales and Growth Rate Forecast of Chronic and Autoimmune Disorders (2020-2025)
Figure Global Biosimilars Market Revenue ($) and Growth Rate Forecast of Others (2020-2025)
Figure Global Biosimilars Sales and Growth Rate Forecast of Others (2020-2025)
Figure Global Biosimilars Sales and Growth Rate (2015-2020)
Table Global Biosimilars Sales by Regions (2015-2020)
Table Global Biosimilars Sales Market Share by Regions (2015-2020)
Figure Global Biosimilars Sales Market Share by Regions in 2019
Figure Global Biosimilars Revenue and Growth Rate (2015-2020)
Table Global Biosimilars Revenue by Regions (2015-2020)
Table Global Biosimilars Revenue Market Share by Regions (2015-2020)
Figure Global Biosimilars Revenue Market Share by Regions in 2019
Table Global Biosimilars Market Forecast Sales by Regions (2020-2025)
Table Global Biosimilars Market Forecast Sales Share by Regions (2020-2025)
Table Global Biosimilars Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Biosimilars Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Biosimilars Market Sales and Growth Rate (2015-2020)
Figure North America Biosimilars Market Revenue and Growth Rate (2015-2020)
Figure North America Biosimilars Market Forecast Sales (2020-2025)
Figure North America Biosimilars Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Canada Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Mexico Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Europe Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Europe Biosimilars Market Revenue and Growth Rate (2015-2020)
Figure Europe Biosimilars Market Forecast Sales (2020-2025)
Figure Europe Biosimilars Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Biosimilars Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Biosimilars Market Sales and Growth Rate (2015-2020)
Figure France Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Italy Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Spain Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Russia Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Biosimilars Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Biosimilars Market Forecast Sales (2020-2025)
Figure Asia-Pacific Biosimilars Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Japan Biosimilars Market Sales and Growth Rate (2015-2020)
Figure South Korea Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Australia Biosimilars Market Sales and Growth Rate (2015-2020)
Figure India Biosimilars Market Sales and Growth Rate (2015-2020)
Figure South America Biosimilars Market Sales and Growth Rate (2015-2020)
Figure South America Biosimilars Market Revenue and Growth Rate (2015-2020)
Figure South America Biosimilars Market Forecast Sales (2020-2025)
Figure South America Biosimilars Market Forecast Revenue ($) (2020-2025)
Figure Brazil Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Argentina Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Columbia Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Biosimilars Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Biosimilars Market Forecast Sales (2020-2025)
Figure Middle East and Africa Biosimilars Market Forecast Revenue ($) (2020-2025)
Figure UAE Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Egypt Biosimilars Market Sales and Growth Rate (2015-2020)
Figure South Africa Biosimilars Market Sales and Growth Rate (2015-2020)


More Publications